Use and cardiovascular safety of transdermal and other granisetron preparations in cancer management
Jay W Mason,1 Thomas E Moon2 1School of Medicine, University of Utah, Salt Lake City, UT, 2Tarizona eHealth Services, Inc, Emeryville, CA, USA Abstract: 5-HT3 antagonists have been available as oral and intravenous preparations for decades. The availability more recently of transdermal granisetron a...
Main Authors: | Mason JW, Moon TE |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2013-07-01
|
Series: | Cancer Management and Research |
Online Access: | http://www.dovepress.com/use-and-cardiovascular-safety-of-transdermal-and-other-granisetron-pre-a13822 |
Similar Items
-
Use of granisetron transdermal system in the prevention of chemotherapy-induced nausea and vomiting: a review
by: Albert Tuca
Published: (2009-12-01) -
Use of transdermal and intravenous granisetron and the ability of the Hesketh score to assess nausea and vomiting induced by multiday chemotherapy
by: Boccia RV, et al.
Published: (2012-07-01) -
A randomized, placebo-controlled, four-period crossover, definitive QT study of the effects of APF530 exposure, high-dose intravenous granisetron, and moxifloxacin on QTc prolongation
by: Mason JW, et al.
Published: (2014-03-01) -
Combination of granisetron-dexamethasone in the prophylaxis of postoperative nausea and vomiting after thyroidectomy : Comparison with granisetron alone
by: A Rudra, et al.
Published: (2005-01-01) -
A Randomized Comparison of Granisetron Plus Dexamethason with Granisetron alone for the Control of Acute Chemotherapy-Induced Emesis and Nausea
by: Shahrbanou Keyhanian, et al.
Published: (2009-06-01)